Sagimet Biosciences Series A Statistics
NASDAQ: SGMTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
9.08-0.54 (-5.61%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Sagimet Biosciences Series A by the numbers
Sagimet Biosciences Series A has a market capitalization of $648.0 million based on 71.37M shares outstanding. With trailing EPS of $-1.18, Sagimet Biosciences Series A is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.0% below its 50-day average and 16.4% above its 200-day average.
Average daily trading volume is 1.23M shares, or about $11.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SGMT valuation vs. peer median
| Metric | SGMT | Peer median | Difference |
|---|---|---|---|
| Market cap | $648.02M | $625.81M | +4% |
| Avg. volume | 1.23M | 1.69M | -27% |
Peer median across 8 companies: KURA, NVCT, APMD, JANX, ABUS, OLMA, LXRX, ANNX.
Valuation
- Market cap
- $648.02M
- EPS (TTM)
- $-1.18
- Shares outstanding
- 71.37M
Price and trading
- Previous close
- 9.62
- Open
- 9.32
- Day range
- 8.83 – 9.40
- 52-week range
- 4.50 – 11.45
- 52-week change
- +36.13%
- Beta
- —
- Volume
- 1.50M
- Average volume
- 1.23M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 648.02M
- Forward Pe
- -6.40
- Eps
- -1.18
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.45
- Week52 Low
- 4.50
- Avg Volume
- 1.23M
- Shares Outstanding
- 71.37M
- Ma50
- 9.77
- Ma200
- 7.80
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -20.69%
- Pct From52w Low
- 101.78%